TUBA1C and cancer: Since downregulation of TUBA1C and PRDX4 proteins was observed only in NVA-AA-treated MDA-MB-231 cells, their downregulated expressions might make MDA-MB-231 sensitive to NVA-AA treatment in the same fashion as shown by cancer cells to THZ-2-102-1 treatments.